Targeted Treatment of the Rheumatic Diseases

Produk Detail:
  • Author : Michael H. Weisman
  • Publisher : Elsevier Health Sciences
  • Pages : 471 pages
  • ISBN : 141609993X
  • Rating : /5 from reviews
CLICK HERE TO GET THIS BOOK >>>Targeted Treatment of the Rheumatic Diseases

Download or Read online Targeted Treatment of the Rheumatic Diseases full in PDF, ePub and kindle. this book written by Michael H. Weisman and published by Elsevier Health Sciences which was released on 18 October 2021 with total page 471 pages. We cannot guarantee that Targeted Treatment of the Rheumatic Diseases book is available in the library, click Get Book button and read full online book in your kindle, tablet, IPAD, PC or mobile whenever and wherever You Like. Michael H. Weisman, Michael Weinblatt, James S Louie, and Ronald Van Vollenhoven offer their unique insights into choosing the correct pharmacological and non-pharmacological therapies for your patients. Chapters cover the full breadth of rheumatic diseases, rheumatoid arthritis, lupus, connective tissue diseases, osteoporosis, regional pain disorders, and fibromyalgia. The full-color design presents detailed clinical photographs and treatment algorithms for visual guidance and easy reference. Covers the treatment of pediatric patients as well as adults so that you can properly address the particular needs of any patient you see. Features the guidance and specific recommendations of experts from United States and Europe for a state-of-the-art approach to the variety of treatments currently in use. Displays the clinical manifestations of rheumatic diseases in full color, along with treatment algorithms for easy at-a-glance reference.

Targeted Treatment of the Rheumatic Diseases

Targeted Treatment of the Rheumatic Diseases
  • Author : Michael H. Weisman
  • Publisher : Elsevier Health Sciences
  • Release : 18 October 2021
GET THIS BOOK Targeted Treatment of the Rheumatic Diseases

Michael H. Weisman, Michael Weinblatt, James S Louie, and Ronald Van Vollenhoven offer their unique insights into choosing the correct pharmacological and non-pharmacological therapies for your patients. Chapters cover the full breadth of rheumatic diseases, rheumatoid arthritis, lupus, connective tissue diseases, osteoporosis, regional pain disorders, and fibromyalgia. The full-color design presents detailed clinical photographs and treatment algorithms for visual guidance and easy reference. Covers the treatment of pediatric patients as well as adults so that you can properly address the

Biologics for the Treatment of Rheumatoid Arthritis

Biologics for the Treatment of Rheumatoid Arthritis
  • Author : Ronald van Vollenhoven
  • Publisher : Springer
  • Release : 22 December 2015
GET THIS BOOK Biologics for the Treatment of Rheumatoid Arthritis

This book provides a comprehensive overview of the available biologic therapies whilst comparing them to standard disease modifying anti-rheumatic drugs, and discusses how best to determine which therapy is most appropriate for an individual patient in the framework of current guidelines. Biologics for the Treatment of Rheumatoid Arthritis is an up-to-date and concise practical guide to the latest therapeutic developments in this field. This book is an invaluable source of topical information for all rheumatologists and health care professionals treating

Contemporary Targeted Therapies in Rheumatology

Contemporary Targeted Therapies in Rheumatology
  • Author : Josef S. Smolen,Peter E. Lipsky
  • Publisher : CRC Press
  • Release : 18 October 2007
GET THIS BOOK Contemporary Targeted Therapies in Rheumatology

Targeted therapies of rheumatic diseases have become a reality and have completely changed patient care as well as patient expectations. Initial success with therapies aimed at blocking TNF and IL-1 has stimulated the development of additional targeted approaches focused on other cytokines as well as specific cells and pathways involved in the path

Treat to Target in Rheumatic Diseases Rationale and Results E Book

Treat to Target in Rheumatic Diseases  Rationale and Results E Book
  • Author : Daniel Aletaha
  • Publisher : Elsevier Health Sciences
  • Release : 10 October 2019
GET THIS BOOK Treat to Target in Rheumatic Diseases Rationale and Results E Book

Guest edited by Dr. Daniel Aletaha, this issue of Rheumatic Disease Clinics will cover “Treat to Target in Rheumatic Diseases with a focus on rationale and results. This issue is one of four selected each year by our series Consulting Editor, Dr. Michael Weisman. Articles explore diseases, including, but not limited to: History, Rheumatoid Arthritis, Psoriatic Arthritis, Spondylarthropathies, Systemic lupus erythematosus, PMR and GCA, Inflammatory Myopathies (PM/DM), Gout, and Subclinical Targets.

Drugs Targeting B Cells in Autoimmune Diseases

Drugs Targeting B Cells in Autoimmune Diseases
  • Author : Xavier Bosch,Manuel Ramos-Casals,Munther A Khamashta
  • Publisher : Springer Science & Business Media
  • Release : 22 November 2013
GET THIS BOOK Drugs Targeting B Cells in Autoimmune Diseases

This book provides a detailed overview of B-cell directed therapies in patients with rheumatic and systemic autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, Sjögren syndrome, ANCA-associated vasculitis and cryoglobulinemia. Organ-specific autoimmune diseases are discussed with respect to the use of B-cell directed therapies in neurological autoimmune diseases and autoimmune cytopenias. Situations in which B-cell targeted therapy may be indicated are identified, thereby offering comprehensive support for therapeutic decisions on the basis of the latest published evidence. The book

Challenges in Rheumatology

Challenges in Rheumatology
  • Author : Miroslav Harjacek
  • Publisher : BoD – Books on Demand
  • Release : 22 December 2011
GET THIS BOOK Challenges in Rheumatology

Rheumatology is a subspecialty of medicine that focuses on the biology, cause, diagnosis and the treatment of a variety of musculoskeletal and other systemic diseases. The field of rheumatology is expanding rapidly and several very exciting developments have occurred during the recent years. Firstly, there has been a new dramatic understanding of the nature of inflammation and the possibility of specifically regulating the aberrant immune inflammatory response. Secondly, an understanding of pathogenesis has lead to the development of new, more